{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:37Z","timestamp":1790101837270,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41372-019-0503-x","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T12:53:46Z","timestamp":1569848026000},"page":"1584-1594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-0765","authenticated-orcid":false,"given":"A.","family":"Stritzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013;382:1445\u201357.","journal-title":"Lancet."},{"key":"503_CR2","unstructured":"Canadian Neonatal N. Annual Report. 2016. http:\/\/www.canadianneonatalnetworkorg\/Portal\/LinkClickaspx?fileticket=PJSDwNECsMI%3d&tabid=39. Accessed 15 Jan 2019."},{"key":"503_CR3","first-page":"228","volume":"6","author":"F Mutlu","year":"2013","unstructured":"Mutlu F, Sarici SU. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol. 2013;6:228\u201336.","journal-title":"Int J Ophthalmol"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"Early Treatment for ROP Cooperative, Group.","year":"2003","unstructured":"Early Treatment for ROP Cooperative, Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Opthalmol. 2003;121:1684\u201394.","journal-title":"Arch Opthalmol"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"H Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner H, Kennedy KA, Chuang AZ. BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Eng J Med. 2011;364:603\u201315.","journal-title":"N Eng J Med."},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","volume":"63","author":"Senthil Selvam","year":"2018","unstructured":"Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res. 2018;63:1\u201319.","journal-title":"Progress in Retinal and Eye Research"},{"issue":"Suppl A","key":"503_CR7","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/j.ghir.2004.03.030","volume":"14","author":"L Smith","year":"2004","unstructured":"Smith L. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res. 2004;14(Suppl A):S140\u20134.","journal-title":"Growth Horm IGF Res."},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","volume":"114","author":"E Pierce","year":"1996","unstructured":"Pierce E, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Opthalmol. 1996;114:1219\u201328.","journal-title":"Arch Opthalmol."},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1091-8531(97)90008-2","volume":"1","author":"T Young","year":"1997","unstructured":"Young T, Anthony DC, Pierce E, Foley E, Smith LE. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J Aapos. 1997;1:105\u201310.","journal-title":"J Aapos."},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Eng J Med. 2015;372:735\u201346.","journal-title":"N Eng J Med."},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","volume":"52","author":"C Ristori","year":"2011","unstructured":"Ristori C, Filippi L, Dal Monte M, Martini D, Cammalleri M, Fortunato P, et al. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Invest Ophthalmol Vis Sci. 2011;52:155\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","volume":"42","author":"G Casini","year":"2014","unstructured":"Casini G, Dal Monte M, Fornaciari I, Filippi L, Bagnoli P. The \u03b2-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases. Prog Retin Eye Res. 2014;42:103\u201329.","journal-title":"Prog Retin Eye Res."},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","volume":"111","author":"M Dal Monte","year":"2013","unstructured":"Dal Monte M, Casini G, la Marca G, Isacchi B, Filippi L, Bagnoli P. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. Exp Eye Res. 2013;111:27\u201335.","journal-title":"Exp Eye Res."},{"issue":"6","key":"503_CR14","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1167\/iovs.12-9691","volume":"53","author":"Jing Chen","year":"2012","unstructured":"Chen J, Joyal JS, Hatton CJ, Juan AM, Pei DT, Hurst CG, et al. Propranolol inhibition of \u03b2-adrenergic receptor does not suppress pathologic neovascularizaion in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2012;53;2968\u201377.","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1651-2227.2011.02330.x","volume":"100","author":"A H\u00e5rd","year":"2011","unstructured":"H\u00e5rd A, Hellstr\u00f6m A. On the use of antiangiogenetic medications for retinopathy of prematurity. Acta Paediatr. 2011;100:1063\u20135.","journal-title":"Acta Paediatr"},{"key":"503_CR16","doi-asserted-by":"crossref","unstructured":"Kaempfen S, Neumann RP, Jost K, Schulzke SM. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants. Cochrane Cochrane Database Syst Rev. 2018;3:CD011893.","DOI":"10.1002\/14651858.CD011893.pub2"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1\u201334.","journal-title":"J Clin Epidemiol"},{"key":"503_CR18","unstructured":"Bancalari A, Schade R, Lazcano C, Munoz T, Sepulveda G. Treatment of retinopathy of prematurity with propranolol: a randomized control trial. PAS-oral presentation. 2018."},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","volume":"128","author":"P Burns","year":"2011","unstructured":"Burns P, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128:305\u201310.","journal-title":"Plast Reconstr Surg."},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Classification of Retinopathy of Prematurity.","year":"2005","unstructured":"International Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol."},{"key":"503_CR21","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. ROB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:14898;1\u20138","DOI":"10.1136\/bmj.l4898"},{"key":"503_CR22","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welche V, Losos M, et al. The Newcastle-Ottawa (NOC) for assessing the quality of nonrandomized studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 15 Jan 2019."},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","volume":"44","author":"A Bancalari","year":"2016","unstructured":"Bancalari A, Schade R, Mu\u00f1oz T, Lazcano C, Parada R, Pena R. Oral propranolol in early stages of retinopathy of prematurity. J Perinat Med. 2016;44:499\u2013503.","journal-title":"J Perinat Med."},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336\u201341.","journal-title":"Int J Surg"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"F389","DOI":"10.1136\/archdischild-2016-311548","volume":"102","author":"K Sanghvi","year":"2017","unstructured":"Sanghvi K, Kabra NS, Padhi P, Singh U, Dash SK, Avasthi BS. Prophylactic propranolol for prevention of ROP and visual outcome at 1\u2005year (PreROP trial). Arch Dis Child Fetal Neonatal Ed. 2017;102:F389\u201394.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","volume":"163","author":"L Filippi","year":"2013","unstructured":"Filippi L, Cavallaro G, Bagnoli P, Dal Monte M, Fiorini P, Donzelli G, et al. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr. 2013;163:1570\u20137.","journal-title":"J Pediatr."},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","volume":"98","author":"I Makhoul","year":"2013","unstructured":"Makhoul I, Peleg O, Miller B, Bar-Oz B, Kochavi O, Mechoulam H, et al. Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study. Arch Dis Child. 2013;98:565\u20137.","journal-title":"Arch Dis Child"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","volume":"42","author":"L Korkmaz","year":"2017","unstructured":"Korkmaz L, Ba\u015ftu\u011f O, Ozdemir A, Korkut S, Karaca C, Akin MA, et al. The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index. Curr Eye Res. 2017;42:88\u201397.","journal-title":"Curr Eye Res"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","volume":"81","author":"L Filippi","year":"2017","unstructured":"Filippi L, Cavallaro G, Bagnoli P, Dal Monte M, Fiorini P, Berti E, et al. Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. Pediatr Res. 2017;81:307\u201314.","journal-title":"Pediatr Res."},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000493723","volume":"115","author":"D Bremond-Gignac","year":"2018","unstructured":"Bremond-Gignac D, Jacqz-Aigrain E, Abdoul H, Daruich A, Beresniak A, Baud O, et al. on behalf of the CLAIR FO study group. Ophthalmic insert versus eye drops for Mydriasis in neonates: a randomized clinical trial. Neonatology. 2018;115:142\u20138.","journal-title":"Neonatology."},{"key":"503_CR31","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/bjophthalmol-2016-310041","volume":"101","author":"B Darlow","year":"2017","unstructured":"Darlow B, Lui K, Kusuda S, Reichman B, H\u00e5kansson S, Bassler D, et al. International Network for Evaluating Outcomes of Neonates. International variations and trends in the treatment for retinopathy of prematurity. Br J Ophthalmol. 2017;101:1399\u2013404.","journal-title":"Br J Ophthalmol."}],"updated-by":[{"DOI":"10.1038\/s41372-019-0537-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000}}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0503-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0503-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0503-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:51:15Z","timestamp":1744177875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0503-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1038\/s41372-019-0503-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41372-019-0537-0","asserted-by":"object"}]},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}